Skip to main content
Default Image

From discovery to delivery: public sector development of the rVSV-ZEBOV Ebola vaccine

Citing The Democracy Collaborative’s Dana Brown on the need for a public option for pharmaceutics, this case study of rVSV-ZEBOV underscores the significant public contribution to the R&D of vaccines even under conditions of precarity, and suggests that an alternative approach to generating knowledge and developing interventions, such as open science, is required in order to fully realize the public sector’s contribution to improved global health.

“One option, which is gaining interest, is to create a ‘public option,’ that is, a public sector led supply of essential, affordably priced medicines from discovery all the way through manufacturing and regulatory approval.[55] Indeed, the case of rVSV-ZEBOV shows that such a public option is not simply theoretical; rather, as demonstrated by the NML, the public sector has the capacity to do much more than pure discovery research. Armed with sufficient resources, public sector labs can conduct phase 1, 2, and 3 clinical trials as well as solve many of the technical challenges that manufacturing a clinical grade vaccine will entail.”

Publication date: 2020-01-16
Parent publication: Journal of Law and the Biosciences
Publication URL: https://academic.oup.com/jlb/advance-article/doi/10.1093/jlb/lsz019/5706941

More related work

Medicine Cost

Americans deserve publicly owned generic drugs

Bold policies could have saved America’s largest generic drug plant, but it’s never too late to start putting communities first.

read more
Illustration courtesy of United Nations

All health is public health: Busting the myths of choice and commodity

For decades, we have been sold a myth of private health. It is a myth that our health is largely a product of individual choices and personal responsibilities. It is a myth that our healthcare is a service that private corporations can provide, and for which we must pay to survive. But the COVID-19

read more
Neil McInroy (Source: Coop News)

Neil McInroy joins TDC to advise stepped-up community wealth building program

The former CEO of a leading UK economic think tank will be central in helping build capacity to offer powerful new technical assistance to cities and local authorities pursuing community wealth building strategies.

read more